|
|
|
Insider
Information: |
Cuss Francis M |
Relationship: |
Director |
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
331,905 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$14,505,609 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
331,905 |
|
|
Total
Value |
$14,505,609 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bristol-Myers Squibb Co |
BMY |
EVP & CSO |
2017-03-10 |
321,905 |
|
0 |
Premium* |
|
Rubius Therapeutics, Inc. |
RUBY |
Director |
2018-07-20 |
10,000 |
2018-07-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RUBY |
Rubius Therapeutics, Inc. |
Director |
|
2018-07-20 |
4 |
B |
$23.00 |
$230,000 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2013-11-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,666 |
201,827 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2013-11-02 |
4 |
D |
$52.48 |
$181,423 |
D/D |
(3,457) |
198,370 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2014-02-18 |
4 |
OE |
$28.11 |
$1,086,929 |
D/D |
38,667 |
237,037 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2014-02-18 |
4 |
S |
$54.61 |
$1,627,360 |
D/D |
(29,800) |
207,237 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2014-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,834 |
218,621 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2014-03-03 |
4 |
D |
$53.49 |
$1,547,359 |
D/D |
(28,928) |
234,096 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2014-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
47,953 |
254,899 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2014-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,010 |
237,106 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2014-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,044 |
239,150 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2014-03-06 |
4 |
D |
$55.56 |
$145,623 |
D/D |
(2,621) |
236,529 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2014-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,739 |
239,268 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2014-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,243 |
240,511 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2014-03-10 |
4 |
D |
$56.14 |
$115,929 |
D/D |
(2,065) |
238,446 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2014-09-16 |
4 |
OE |
$24.74 |
$1,602,575 |
D/D |
63,667 |
302,113 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2014-09-16 |
4 |
S |
$50.77 |
$3,232,074 |
D/D |
(63,667) |
238,446 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2014-11-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,666 |
245,112 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2014-11-02 |
4 |
D |
$58.19 |
$201,163 |
D/D |
(3,457) |
241,655 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2015-03-02 |
4 |
D |
$62.30 |
$171,886 |
D/D |
(2,759) |
246,302 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2015-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,703 |
249,061 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,703 |
245,358 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2015-03-02 |
4 |
D |
$62.30 |
$696,327 |
D/D |
(11,177) |
258,928 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,803 |
270,105 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2015-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,802 |
264,739 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
|
2015-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,009 |
261,937 |
0 |
- |
|
80 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|